Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumescent technique versus tumescent plus tranexamic acid versus normal saline in burn surgery
IRCT20250317065110N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of epinephrine, tranexamic acid and sodium chloride in burn injury (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Amount of blood lost during surgery, Occurrence of bleeding after surgery and 8 more. Started Apr 2025; status: completed.
02
Drugs
epinephrinetranexamic acidsodium chloride
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20250317065110N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250317065110N1.